Friday, October 2, 2026
| 3:00 PM |
Registration
|
| 4:00-4:45 PM |
Multiple Sclerosis Update & McDonald Criteria
|
| 4:45-5:30 PM |
The Role of Glucagon-like Peptide-1 Agonists in Multiple Sclerosis
|
| 5:30-6:15 PM | Autonomic Neurology
|
| 6:15-6:30 PM |
Welcome & Social Break
|
| 6:30-7:30 PM |
Keynote | From Dollars to Donuts: What’s New in Global Neurology? |
7:30-9:00 PM |
Reception & Poster Viewing
|
Saturday, October 3, 2026
| 7:00 AM |
Breakfast
|
| 8:00-8:45 AM |
Epilepsy Surgery and Neuromodulation: Who, What, Why, and When?
|
| 8:45-9:30 AM |
Searching for the Holy Grail: Clinical Trials of Disease Modifying Therapies in Huntington's Disease
|
| 9:30-10:15 AM |
Shared priorities in Neurology: AAN strategy, brain health and state engagement
|
| 10:15-10:45 AM |
Break with Exhibitors
|
| 10:45-11:30 AM |
Transitional Role from Pediatrics to Adults
|
| 11:30 AM-12:15 PM | SMA Drug Updates (Pediatrics & Adults)
|
| 12:15-1:15 PM |
Lunch & Annual Business Meeting
|
| 1:15-2:15 PM | 3 New Things in Neurology (Topics include: APP Role in Epilepsy, Stroke, Headache)
|
| 2:15-2:30 PM |
Break with Exhibitors
|
| 2:30-3:30 PM | How to meet the Workforce needs of Neurology in Rural Wisconsin?
|
| 3:30-4:30 PM |
Forster Awards: Resident Abstract Competition |
| |
|
Friday, October 3, 2025ay, October 3, 2025
